In fairness to Z he went "all in" on the previous tip, and that hasn't turned out so well. So it would pay to regard the "tips" as just that, and there are no specifics or guarantees, so I don't think its worth getting too excited over
Everybody knows that LCT has quite a few irons in the fire which could provide positive news (Diabecell with Otsuka, collaboration with the CBR), but to date we've all been disappointed.... although it does seem that its as least as much bad luck as bad management.
But nonetheless its been very disappointing for everyone involved, investors, the company, the researchers and the patients.
LCT Price at posting:
2.9¢ Sentiment: Hold Disclosure: Held
